Select Medical Corporation
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Select Medical Holdings Corporation (SEM) is a U.S.-based healthcare organization that manages a diverse portfolio of specialized medical facilities. The company operates across four primary divisions...
Latest News
4 months ago · prnewswire.com
Select Medical Holdings Corporation Acquired by Consortium Led by Robert A. Ortenzio, Martin F.MECHANICSBURG, Pa., June 30, 2026 /PRNewswire/ -- Select Medical Holdings Corporation (the "Company" or "Select Medical," "we," "us," or "our") (NYSE: SEM) today announced the completion of its acquisition by an entity affiliated with a consortium led by Robert A.
4 months ago · prnewswire.com
Select Medical Holdings Corporation Announces Stockholder Approval of Acquisition by Consortium Led by Robert A. Ortenzio, Martin F.MECHANICSBURG, Pa., June 26, 2026 /PRNewswire/ -- Select Medical Holdings Corporation (NYSE: SEM) ("Select Medical," "we," "us," or "our") confirmed today that its previously announced Agreement and Plan of Merger (the "Merger Agreement," and the transaction contemplated thereby, the "Merger") with an entity affiliated with a consortium led by Robert A.
5 months ago · globenewswire.com
$SEM Investigation Notice: BFA Law is Investigating the Select Medical Board for Breaching its Duties to Shareholders after $16.50 Acquisition AnnouncedNEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?
5 months ago · globenewswire.com
SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition – Current Shareholders Urged to Contact BFA LawNEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?
5 months ago · globenewswire.com
$SEM Stock Drop Reminder: Select Medical Announces $16.50 per share Acquisition – BFA Law's Investigation into the Board is OngoingNEW YORK, June 12, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?
5 months ago · globenewswire.com
Select Medical Investigation: Select Medical (SEM) Board Investigated after Announcing $16.50 per share Acquisition – Contact BFA Law if You Hold SharesNEW YORK, June 10, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?
5 months ago · globenewswire.com
Attention Select Medical Investors: Kaskela Law LLC is Investigating the Proposed $16.50 Per Share Shareholder Buyout and Encourages Investors to Contact the Firm to Protect Their InvestmentNEWTOWN SQUARE, Pa., June 09, 2026 (GLOBE NEWSWIRE) -- Shareholder protection law firm Kaskela Law is investigating the recently announced buyout of Select Medical Holdings Corp. (NYSE: SEM) (“Select Medical”) shareholders to determine whether the transaction as structured is fair and provides investors with a sufficient premium for their SEM shares.
5 months ago · globenewswire.com
$SEM Securities Notice: BFA Law Notifies Select Medical Shareholders the Pending Investigation into the $16.50 per share AcquisitionNEW YORK, June 08, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?
5 months ago · globenewswire.com
$SEM Stock Notification: Current Shareholder of Select Medical? Contact BFA Law about its Ongoing Investigation into the Board Over $16.50 per share AcquisitionNEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?
5 months ago · businesswire.com
SEM Alert: BFA Law Reminds Select Medical Shareholders of its Pending Investigation into the Board after $16.50 per share Acquisition is AnnouncedNEW YORK--(BUSINESS WIRE)---- $SEM #BFA--BFA Law Reminds Select Medical Shareholders of its Pending Investigation into the Board after $16.50 per share Acquisition is Announced.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove SEM